Aravind Prasad

Aravind Prasad is a seasoned computational chemist with extensive experience in drug discovery and development across multiple prestigious organizations. Currently with TRIANA Biomedicines since February 2022, Aravind has previously held roles at Constellation Pharmaceuticals, Bristol Myers Squibb, Celgene, Avila Therapeutics, IndiScine Biosciences, and Biogen Idec, contributing significantly to the establishment of computational chemistry functions and innovative platforms. Aravind's expertise encompasses molecular dynamics, machine learning applications in cheminformatics, druggability assessments, and the integration of computational strategies into drug discovery programs. Aravind holds a Master’s degree in Bioinformatics from Northeastern University and a Bachelor’s degree in Electronics and Communications Engineering.